Related Experiment Video
Updated: Aug 15, 2026

Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins
Published on: July 1, 2011
Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily
1Laboratory of Intracellular Parasites, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratory, Hamilton, Montana 59840, USA. kwolf@niaid.nih.gov
Abstract:
The major outer membrane protein (MOMP) of Chlamydia trachomatis serovariants is known to be an immunodominant surface antigen. Moreover, it is known that the C. trachomatis MOMP elicits antibodies that recognize both linear and conformational antigenic determinants. In contrast, it has been reported that the MOMP of Chlamydia pneumoniae is not surface exposed and is immunorecessive. We hypothesized that the discrepancies between C. trachomatis and C. pneumoniae MOMP exposure on intact chlamydiae and immunogenic properties might be because the focus of the host's immune response is directed to conformational epitopes of the C. pneumoniae MOMP. We therefore conducted studies aimed at defining the surface exposure of MOMP and the conformational dominance of MOMP antibodies. We present here a description of C. pneumoniae species-specific monoclonal antibody (MAb), GZD1E8, which recognizes a conformational epitope on the surface of C. pneumoniae. This MAb is potent in the neutralization of C. pneumoniae infectivity in vitro. Another previously described C. pneumoniae species-specific monoclonal antibody, RR-402, displayed very similar characteristics. However, the antigenic determinant recognized by RR-402 has yet to be identified. We show by immunoprecipitation of C. pneumoniae with GZD1E8 and RR-402 MAbs and by mass spectrometry analysis of immunoprecipitated proteins that both antibodies GZD1E8 and RR-402 recognize the MOMP of C. pneumoniae and that this protein is localized on the surface of the organism. We also show that human sera from C. pneumoniae-positive donors consistently recognize the MOMP by immunoprecipitation, indicating that the MOMP of C. pneumoniae is an immunogenic protein. These findings have potential implications for both C. pneumoniae vaccine and diagnostic assay development.
Insights
The major outer membrane protein (MOMP) of Chlamydia pneumoniae is surface-exposed and immunogenic, contrary to previous beliefs. This finding supports the development of new vaccines and diagnostic tools for Chlamydia pneumoniae infections.
Area of Science:
- Microbiology
- Immunology
- Bacterial Pathogenesis
Background:
- The major outer membrane protein (MOMP) of Chlamydia trachomatis is a known surface antigen eliciting antibodies.
- In contrast, Chlamydia pneumoniae MOMP was considered non-surface-exposed and immunorecessive, leading to questions about immune response focus.
- Discrepancies in MOMP properties between C. trachomatis and C. pneumoniae suggested differences in epitope recognition.
Purpose of the Study:
- To investigate the surface exposure and immunogenic properties of Chlamydia pneumoniae MOMP.
- To define conformational epitopes on C. pneumoniae MOMP recognized by specific monoclonal antibodies.
- To assess the potential of C. pneumoniae MOMP as a target for vaccines and diagnostics.
Main Methods:
- Generation and characterization of Chlamydia pneumoniae-specific monoclonal antibodies (MAbs), GZD1E8 and RR-402.
- Immunoprecipitation assays using MAbs to identify target antigens.
- Mass spectrometry analysis to confirm protein identity.
- In vitro infectivity neutralization assays.
- Analysis of human sera from C. pneumoniae-positive donors.
Main Results:
- Monoclonal antibody GZD1E8 recognizes a surface-exposed conformational epitope on C. pneumoniae MOMP.
- GZD1E8 demonstrated potent in vitro neutralization of C. pneumoniae infectivity.
- Both GZD1E8 and RR-402 MAbs immunoprecipitated C. pneumoniae MOMP, confirming its surface localization.
- Human sera from C. pneumoniae-positive individuals recognized MOMP, indicating its immunogenicity.
Conclusions:
- Chlamydia pneumoniae MOMP is surface-exposed and immunogenic, challenging previous assumptions.
- The identified conformational epitopes on MOMP are targets for neutralizing antibodies.
- These findings have significant implications for developing effective Chlamydia pneumoniae vaccines and diagnostic assays.
More Related Videos
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
06:04Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Formation of Lipopolysaccharides
Bacterial Phylum Chlamydiae
Streptococcal Pharyngitis
Atypical Pneumonia